<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/232FE897-4F2F-40BD-A92F-28CE006F8158"><gtr:id>232FE897-4F2F-40BD-A92F-28CE006F8158</gtr:id><gtr:name>San Raffaele del Monte Tabor Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6D9EC04E-A8C7-41B8-8568-E22835C67417"><gtr:id>6D9EC04E-A8C7-41B8-8568-E22835C67417</gtr:id><gtr:name>Structural and Computational Biology &amp; Molecular Biophysics</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/30E23543-9C9E-4F81-9F88-311D9A449F25"><gtr:id>30E23543-9C9E-4F81-9F88-311D9A449F25</gtr:id><gtr:name>Department of Medical Biochemistry and Biophysics</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/232FE897-4F2F-40BD-A92F-28CE006F8158"><gtr:id>232FE897-4F2F-40BD-A92F-28CE006F8158</gtr:id><gtr:name>San Raffaele del Monte Tabor Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6D9EC04E-A8C7-41B8-8568-E22835C67417"><gtr:id>6D9EC04E-A8C7-41B8-8568-E22835C67417</gtr:id><gtr:name>Structural and Computational Biology &amp; Molecular Biophysics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/30E23543-9C9E-4F81-9F88-311D9A449F25"><gtr:id>30E23543-9C9E-4F81-9F88-311D9A449F25</gtr:id><gtr:name>Department of Medical Biochemistry and Biophysics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1CB4512E-B662-46F2-BFFD-915274941D56"><gtr:id>1CB4512E-B662-46F2-BFFD-915274941D56</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Franklin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6E21A7D6-BE0F-45B5-9AAD-25FE1CE982B1"><gtr:id>6E21A7D6-BE0F-45B5-9AAD-25FE1CE982B1</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:surname>ffrench-Constant</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300336"><gtr:id>37400F2F-940D-4811-A810-BC069E35D14C</gtr:id><gtr:title>Enhancing stem cell delivery into the CNS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300336</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>194429</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Medical Biochemistry and Biophysics</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Research Division of Biochemistry</gtr:department><gtr:description>EU FP7 neuromatrix invitation</gtr:description><gtr:id>DB451CE2-0ABC-4F28-B2A1-BA7681E0F59C</gtr:id><gtr:impact>Application to EU</gtr:impact><gtr:partnerContribution>expertise in laminin biology for our stem cell work</gtr:partnerContribution><gtr:piContribution>Invited to join FP7 application based on our expertise in integrin signalling in neural stem cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Structural and Computational Biology &amp; Molecular Biophysics</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Bioengineering</gtr:department><gtr:description>Quantum grant collaboration</gtr:description><gtr:id>8382D37A-D669-4BDB-BA73-05A6B81D4AA6</gtr:id><gtr:impact>Publication in J Neurosci</gtr:impact><gtr:partnerContribution>expertise in hydrogel engineering to create artificial niches using endothelial cells - with our contribution being an understanding of stem cell/endothelial cell interactions</gtr:partnerContribution><gtr:piContribution>expertise in stem and endothelial cell biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Yale University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine Yale</gtr:department><gtr:description>yale</gtr:description><gtr:id>3E826C23-F84A-4B54-BA5E-770FB61BC5A9</gtr:id><gtr:impact>Grant from NIH</gtr:impact><gtr:partnerContribution>expertise in vascular biology and stroke models</gtr:partnerContribution><gtr:piContribution>Expertise in stem cell biology and extracellular matrix</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>San Raffaele del Monte Tabor Foundation</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>San Raffaele Scientific Institute (SRSI)</gtr:department><gtr:description>integrin signalling in stem cell entry into CNS</gtr:description><gtr:id>9AED328F-CED8-4C10-BDC0-D990F1AAFF31</gtr:id><gtr:impact>NMSS grant award</gtr:impact><gtr:partnerContribution>Partnership in successful NMSS grant application and ongoing collaborative work</gtr:partnerContribution><gtr:piContribution>Knowledge of integrin signalling</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>CffC/Karolinska</gtr:description><gtr:id>26671FC2-0602-4E46-8852-F2DA67FF31A9</gtr:id><gtr:impact>List of ECM genes expressed in develiping CNS</gtr:impact><gtr:partnerContribution>Generation of RNAseq datasets</gtr:partnerContribution><gtr:piContribution>Expertise in neural stem cell biology and extracellular matrix</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>RSE lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>76EB861E-31FA-4FDE-AA70-F49CA0926660</gtr:id><gtr:impact>Discussion about MS therapies

None</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Film evening</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>03104E44-30D8-4037-8A76-50453F9B4FF1</gtr:id><gtr:impact>Chaired discussion after film to public on regenerative medicine &amp;quot;filmosophy&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talks to MS Society meetings</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9E2513BB-9E8F-414D-95E1-4A557F00FCED</gtr:id><gtr:impact>Platform presentations at MS Meetings for patients

Dissemination of information, and funding donations to Society</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh science festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8A8C3C86-EC07-4341-9780-972B22A5C47A</gtr:id><gtr:impact>Questions afterwards

none</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Charles frrench-Constant lecture at MS Space North annual meeting 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F27EAFD3-687A-4940-B5FE-A708E2474FD7</gtr:id><gtr:impact>MS Space North annual meeting, 16 August 2013, Exhibition Centre, Aberdeen, Scotland. Prof Charles ffrench-Constant was invited to give a keynote lecture. 150 patients with MS and their families attended. Lecture was recorded and is available online (214 views so far): http://www.mssociety.org.uk/ms-events/2013/06/ms-space-north-2013-aberdeen.

Part of a general objective of disseminating information concerning regenerative medicine, generating interest in this field.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.mssociety.org.uk/ms-events/2013/06/ms-space-north-2013-aberdeen</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>US MS Society Promise 2010</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>National Multiple Sclerosis Society</gtr:fundingOrg><gtr:id>B0909A33-ADFB-48FF-931E-802F75325598</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Investigator award</gtr:description><gtr:end>2020-02-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>EFF16B6E-8BD7-4296-847E-5F2F01354220</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Quantum Grant</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>38DF4C9D-95C5-4239-9C43-3409F610CD32</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Edinburgh - MS Society Clinical Science Centre</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Multiple Sclerosis Society</gtr:fundingOrg><gtr:id>B8E5417C-A14A-4281-93FB-9F1DC6A9EECF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BIRAX</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>20BF1C97-3D08-43B5-8F61-DFF63FF7097C</gtr:id><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Bristol review</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2F992DD-8796-4F7C-9583-39956EAE270D</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Panel discussion at the House of Lords. Tuesday 30 October 2012, London. Charles ffrench-Constant was aksed to give evidence to the Science and Technology Select Committee at the House of Lords. They recently launched their regenerative medicine inquiry and Charles was asked to give oral evidence by being a member of panel (session lasted 55min). In accordance with Lords usual practice, possible questions were provided in advance and the session were be in public and transcribed. The House of Lords Science and Technology Committee, under the Chairmanship of Lord Krebs, is conducting an inquiry into regenerative medicine. The Committee will be looking, in particular, at whether the UK is in a position to facilitate the translation of knowledge from world-leading research to treatments and to benefit from thecommercial opportunities that they present. It also seeks to explore how realistic some of the reported claims of regenerative treatments and therapies are, both in the UK andinternationally.</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C9D6DD13-B653-4DD8-BD38-505E88F38692</gtr:id><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>enables transplanted cells to be identified without further labelling</gtr:description><gtr:id>4A2FB86C-81C9-4871-A508-98F5756C9AE2</gtr:id><gtr:impact>Used in other projects in the lab</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>GFP labelled rats for derivation of cells for transplantation</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39197363-ED77-4FE1-B529-80B967B69846"><gtr:id>39197363-ED77-4FE1-B529-80B967B69846</gtr:id><gtr:title>Extracellular Matrix Regulation of Stem Cell Behavior.</gtr:title><gtr:parentPublicationTitle>Current stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af0707d338e2c1c3c05688ae01f64aed"><gtr:id>af0707d338e2c1c3c05688ae01f64aed</gtr:id><gtr:otherNames>Ahmed M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F1927B99-61DF-4468-BFE5-4AA34A992702"><gtr:id>F1927B99-61DF-4468-BFE5-4AA34A992702</gtr:id><gtr:title>Remyelination in the CNS: from biology to therapy.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d469ddfcd9562b3972ffe34f974f7d21"><gtr:id>d469ddfcd9562b3972ffe34f974f7d21</gtr:id><gtr:otherNames>Franklin RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/829516C7-9046-449C-9385-B8FACCB173F0"><gtr:id>829516C7-9046-449C-9385-B8FACCB173F0</gtr:id><gtr:title>Neuroprotection and repair in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d469ddfcd9562b3972ffe34f974f7d21"><gtr:id>d469ddfcd9562b3972ffe34f974f7d21</gtr:id><gtr:otherNames>Franklin RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0DCE9567-EC62-42E8-9501-795900E0AFF9"><gtr:id>0DCE9567-EC62-42E8-9501-795900E0AFF9</gtr:id><gtr:title>VEGF preconditioning leads to stem cell remodeling and attenuates age-related decay of adult hippocampal neurogenesis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/83e37713650da3c002987c3cffbe74d1"><gtr:id>83e37713650da3c002987c3cffbe74d1</gtr:id><gtr:otherNames>Licht T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0FFC80C5-86F0-4FD7-B744-A4CA951427CE"><gtr:id>0FFC80C5-86F0-4FD7-B744-A4CA951427CE</gtr:id><gtr:title>M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d39740dc3318268969ee29b33db6d59"><gtr:id>0d39740dc3318268969ee29b33db6d59</gtr:id><gtr:otherNames>Miron VE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/371C46C1-E425-48B5-B10C-68B9E740DE6D"><gtr:id>371C46C1-E425-48B5-B10C-68B9E740DE6D</gtr:id><gtr:title>Hypomyelinating leukodystrophies: translational research progress and prospects.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbcf863d1bb205ae712260ac92374b39"><gtr:id>fbcf863d1bb205ae712260ac92374b39</gtr:id><gtr:otherNames>Pouwels PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD68FF39-17D0-4C75-A99A-59EA7DD0BBF1"><gtr:id>DD68FF39-17D0-4C75-A99A-59EA7DD0BBF1</gtr:id><gtr:title>Adhesion molecules in the stem cell niche--more than just staying in shape?</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/318038a6dd38f314c4c55c526557b723"><gtr:id>318038a6dd38f314c4c55c526557b723</gtr:id><gtr:otherNames>Marthiens V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48F49BF1-95B9-404B-A409-5D4CBE905A59"><gtr:id>48F49BF1-95B9-404B-A409-5D4CBE905A59</gtr:id><gtr:title>Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a16f5e538385a01670bdce9acbab2cb1"><gtr:id>a16f5e538385a01670bdce9acbab2cb1</gtr:id><gtr:otherNames>Kazanis I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300336</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>